Back to today’s briefing

Story perspectives

74% of U.S. Adults Struggle with Obesity; GLP-1 Offers Hope

5/29/2025

50 8

Summary

Story summary

A staggering 74% of U.S. adults aged 20 and older grapple with overweight or obesity, heightening their vulnerability to serious health issues. Enter GLP-1, a hormone that inspires synthetic drugs like semaglutide, offering hope for weight management. Coupled with effective dietary strategies and guidance from healthcare professionals, individuals can pursue healthier, side-effect-free lives.

1 of 1

Story summary

A staggering 74% of U.S. adults aged 20 and older grapple with overweight or obesity, heightening their vulnerability to serious health issues. Enter GLP-1, a hormone that inspires synthetic drugs like semaglutide, offering hope for weight management. Coupled with effective dietary strategies and guidance from healthcare professionals, individuals can pursue healthier, side-effect-free lives.